Author

C. McSharry

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. Elmesmari· 1 shared A. F. Rupp· 1 shared A. J. Chalmers· 1 shared B. Tolusso· 1 shared D. Somma· 1 shared E. Curley· 1 shared E. Gremese· 1 shared E. Onwubiko· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Elmesmari

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Low-dose lung radiotherapy for COVID-19 lung disease: a pre-clinical efficacy study in a bleomycin model of pneumonitis.

M. R. Jackson, K. Stevenson, S. K. Chahal, E. Curley, G. Finney, R. Gutierrez-Quintana, E. Onwubiko, A. F. Rupp, K. Strathdee, M. K. MacLeod, C. McSharry, A. J. Chalmers

This study evaluates low-dose lung radiotherapy (LDLR) in a bleomycin pneumonitis model, finding that 1.0 Gy LDLR improves recovery and reduces inflammation, particularly in moderate cases.

bioRxiv · Mar 3, 2021Immunology

COVID-19 and Rheumatoid Arthritis share myeloid pathogenic and resolving pathways

L. MacDonald, T. D. Otto, A. Elmesmari, B. Tolusso, D. Somma, C. McSharry, E. Gremese, I. B. McInnes, S. Alivernini, M. Kurowska-Stolarska

This study identifies shared myeloid pathways between COVID-19 pneumonitis and RA synovitis, highlighting MerTK as a therapeutic target for both conditions.

bioRxiv · Jul 26, 2020 · PreprintImmunology